GoodRx vs HealthStream, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- GoodRx is the larger company by market value: $1.2 B against $1.0 B for HealthStream, Inc., 1.1 times as much (market caps of Oct 14, 2026).
- GoodRx had more revenue: $797 M against $304 M for HealthStream, Inc., both in the year to December 2025.
- GoodRx earned more: net income of $30 M against $18 M for HealthStream, Inc.
- HealthStream, Inc. keeps more of each dollar of sales: a net margin of 6.0% against 3.8% for GoodRx.
- On price to earnings, GoodRx trades at 72.4× and HealthStream, Inc. at 50.5×: investors pay more for each dollar of GoodRx's profit.
- HealthStream, Inc.'s revenue grew faster in its latest fiscal year: +4.3% against +0.6% for GoodRx.
- Their Altman Z-scores put GoodRx in the distress zone and HealthStream, Inc. in the safe zone.
Market value, the same start = 100
From Jan 2021: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | GoodRx GDRX · #8,585 in the world | HealthStream, Inc. HSTM · #9,184 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | 2011 | — |
| Size | ||
| Market cap | $1.2 B | $1.0 B |
| Revenue | $797 M | $304 M |
| Net income | $30 M▲ best | $18 M |
| Employees | 954 | — |
| Valuation | ||
| P/E ratio | 72.4× | 50.5× |
| Price to sales | 1.5× | 3.1× |
| Price to book | 1.9× | 2.9× |
| Free cash flow yield | 14.0%▲ best | 5.8% |
| Profitability | ||
| Operating margin | 11.0%▲ best | 6.7% |
| Net margin | 3.8% | 6.0%▲ best |
| Return on equity | 4.5% | 5.1%▲ best |
| Return on invested capital | 5.8% | — |
| Growth | ||
| Revenue growth | 0.6% | 4.3%▲ best |
| Revenue growth, 3 years a year | 1.3% | 4.5%▲ best |
| Earnings per share growth | 125.0%▲ best | -7.6% |
| Financial strength | ||
| Debt to equity | 0.8× | — |
| Net debt to EBITDA | 1.4× | — |
| Cash | ||
| Free cash flow margin | 20.6%▲ best | 19.6% |
| Shareholder returns | ||
| Dividend yield | — | 0.4% |
| Shareholder yield | 18.4%▲ best | 3.3% |
| Altman Z-score zone | distress | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, GoodRx or HealthStream, Inc.?
GoodRx is the larger company by market value: $1.2 B against $1.0 B for HealthStream, Inc., 1.1 times as much (market caps of Oct 14, 2026).
Which makes more money, GoodRx or HealthStream, Inc.?
GoodRx had more revenue: $797 M against $304 M for HealthStream, Inc., both in the year to December 2025. GoodRx earned more: net income of $30 M against $18 M for HealthStream, Inc.
Which is more profitable, GoodRx or HealthStream, Inc.?
HealthStream, Inc. keeps more of each dollar of sales: a net margin of 6.0% against 3.8% for GoodRx.
Is GoodRx cheaper than HealthStream, Inc.?
On price to earnings, GoodRx trades at 72.4× and HealthStream, Inc. at 50.5×: investors pay more for each dollar of GoodRx's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, GoodRx or HealthStream, Inc.?
HealthStream, Inc.'s revenue grew faster in its latest fiscal year: +4.3% against +0.6% for GoodRx.
Which is financially stronger, GoodRx or HealthStream, Inc.?
Their Altman Z-scores put GoodRx in the distress zone and HealthStream, Inc. in the safe zone.